http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107515304-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107515304-B |
| titleOfInvention | Kidney cancer marker PDZK1 and its application |
| abstract | The invention relates to the fields of molecular biology and tumor medicine, and relates to the application of a novel and specific renal cancer marker PDZK1 in the diagnosis, prognosis and molecular targeted therapy of renal cancer. The invention combines expression profile chip and proteomics method to screen differentially expressed proteins in renal cancer tissue and adjacent tissue, and finds that PDZK1 is significantly low-expressed in renal cancer tissue, and then identifies it by conventional biochemical and molecular biology methods The identification of PDZK1 as a new specific renal cancer marker can further provide new ideas for the research on the pathogenesis of renal cancer, the diagnosis of renal cancer and the prediction of the prognosis of patients, and also provide a new target for the treatment of renal cancer. |
| priorityDate | 2016-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.